在配对的外部与本机构双参数MRI扫描上对既往开发的前列腺病灶深度学习检测算法进行外部验证
本单中心回顾性研究纳入2015年5月至2022年5月在外院行前列腺MRI并在作者机构重新扫描的201例男性患者,评估基于双参数MRI的病灶检测AI模型在配对数据集上的表现。AI对外部MRI上总体病灶和临床显著前列腺癌阳性病灶的检出率分别为39.7%和61%,均低于本机构MRI的56.0%和79%(P < .001)。
要点
- AI模型在外部双参数MRI上检出总体病灶39.7%、临床显著前列腺癌病灶61%,均低于本机构扫描的56.0%和79%。
- 外部MRI上总体病灶检出率随PI-RADS评分(OR=1.57)、病灶直径(OR=3.96)及弥散加权成像质量(OR=1.53)升高而提高。
- 外部MRI上临床显著前列腺癌检出率与两次MRI间隔较短(OR=0.58)及病灶较大(OR=10.19)相关。
核心结论
- AI模型在外部双参数MRI扫描上识别总体病灶和临床显著前列腺癌阳性病灶的表现均为中等。
研究设计与样本
- 单中心回顾性研究,纳入2015年5月至2022年5月在外院行前列腺MRI并在作者机构重新扫描的201例男性患者,由泌尿生殖放射科医生按PI-RADS v2.0或2.1前瞻性判读本机构MRI并对所有扫描行回顾性图像质量评估,部分患者行MRI/US融合引导活检,既往基于完全独立数据集开发的双参数MRI病灶检测AI模型在两个MRI数据集上测试。
诊断标准与关键数值
- 外部MRI扫描上AI检出前列腺内病灶39.7%(149/375),本机构MRI扫描上检出56.0%(210/375)(P < .001);外部MRI扫描上AI检出临床显著前列腺癌阳性病灶61%(54/89),本机构MRI扫描上检出79%(70/89)(P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate the performance of an artificial intelligence (AI) model in detecting overall and clinically significant prostate cancer (csPCa)-positive lesions on paired external and in-house biparametric MRI (bpMRI) scans and assess performance differences between each dataset. Materials and Methods This single-center retrospective study included patients who underwent prostate MRI at an external institution and were rescanned at the authors' institution between May 2015 and May 2022. A genitourinary radiologist performed prospective readouts on in-house MRI scans following the Prostate Imaging Reporting and Data System (PI-RADS) version 2.0 or 2.1 and retrospective image quality assessments for all scans. A subgroup of patients underwent an MRI/US fusion-guided biopsy. A bpMRI-based lesion detection AI model previously developed using a completely separate dataset was tested on both MRI datasets. Detection rates were compared between external and in-house datasets with use of the paired comparison permutation tests. Factors associated with AI detection performance were assessed using multivariable generalized mixed-effects models, incorporating features selected through forward stepwise regression based on the Akaike information criterion. Results The study included 201 male patients (median age, 66 years [IQR, 62-70 years]; prostate-specific antigen density, 0.14 ng/mL2 [IQR, 0.10-0.22 ng/mL2]) with a median interval between external and in-house MRI scans of 182 days (IQR, 97-383 days). For intraprostatic lesions, AI detected 39.7% (149 of 375) on external and 56.0% (210 of 375) on in-house MRI scans (P < .001). For csPCa-positive lesions, AI detected 61% (54 of 89) on external and 79% (70 of 89) on in-house MRI scans (P < .001). On external MRI scans, better overall lesion detection was associated with a higher PI-RADS score (odds ratio [OR] = 1.57; P = .005), larger lesion diameter (OR = 3.96; P < .001), better diffusion-weighted MRI quality (OR = 1.53; P = .02), and fewer lesions at MRI (OR = 0.78; P = .045). Better csPCa detection was associated with a shorter MRI interval between external and in-house scans (OR = 0.58; P = .03) and larger lesion size (OR = 10.19; P < .001). Conclusion The AI model exhibited modest performance in identifying both overall and csPCa-positive lesions on external bpMRI scans. Keywords: MR Imaging, Urinary, Prostate Supplemental material is available for this article. © RSNA, 2024.
引用
- Yilmaz EC, Harmon SA, Law YM, et al. External Validation of a Previously Developed Deep Learning-based Prostate Lesion Detection Algorithm on Paired External and In-House Biparametric MRI Scans. Radiol Imaging Cancer. 2024. PMID: 39400232. doi:10.1148/rycan.240050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。